Search

everythinglearnresearchcommunity

for

Search:↓

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Alopecia areata significantly increases anxiety, depression, and reduces quality of life.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

A new medical syndrome may include skin changes, hair loss, sweating issues, bone malformations, leg swelling, and low cortisol.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Genetic factors can help predict male pattern baldness risk.

"HairSentinel" accurately detects hairfall trends using simple user data, helping identify health risks early.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Consumers prefer general hair care products over those specifically for hair loss.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Higher unemployment rates are linked to increased suicide rates, especially in men aged 25-49 in France.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Early treatment of acne is crucial to prevent scarring and psychological effects.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Effective acne treatment varies by type, with topical and oral medications showing strong evidence, and patient education and support are crucial.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.